Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Organ Preservation Companies

Organ preservation involves the process of maintaining organs outside the body for transplantation. Various companies focus on developing and providing technologies and solutions for organ preservation, ensuring the organs remain viable and functional before transplantation.

Organ Preservation Key Companies

Latest Organ Preservation Companies Update

Oct 2023: For a maximum of $5.8 billion, Bristol-Myers Squibb said that it will buy cancer manufacturer Mirati Therapeutics. The company intends to partially offset the revenue loss anticipated from patent expirations in the coming years by broadening its oncology business and acquiring new medications. Bristol will acquire Mirati's portfolio of medications, which includes the December-approved lung cancer treatment Krazati, that target the genetic causes of tumors. The business was also drawn to a second molecule, MRTX1719, which may be employed in certain lung cancer cases. The business announced its plan to purchase Mirati for cash for $58 per share, or roughly $4.8 billion.

Jul 2023: The heart-lung machine priming research by organ transplant medtech startup XVIVO Perfusion AB has ended, and the business has announced that it will now assess the product's commercial potential. In 2017, the solution known as PrimECC showed encouraging safety outcomes. The new trial was started in 2020, and the Swedish company hoped it would increase the size of the clinical dataset for PrimECC. However, XVIVO identified general difficulties in locating recruiting locations, non-fulfillment of criteria, and COVID-19-related patient enrollment issues as explanations for the trial's failures. The 2016 CE-marked solution keeps air bubbles from getting into the bloodstream by being introduced to heart-lung machines used in cardiopulmonary bypass surgeries. Right now, saline is applied.

List of Organ Preservation Key companies in the market

Trans Medics Group Inc.

Bristol Myers Squibb

Artivion Inc.

Xvivo Perfusion AB

Accord Healthcare Limited

BioLife Solutions Inc.

Shanghai Genext Medical Technology Co.Ltd.

Organ Preservation Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.